Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

BioDelivery Sciences resubmits NDA for Onsolis to FDA

Dec. 18, 2008

Phase IIa clinical trial results of LX-6171 in AAMI lead to reevaluation of future development

Dec. 18, 2008

FDA issues complete response letter denying approval to Pain's NDA for Remoxy

Dec. 18, 2008

FDA approves Athersys' IND to initiate phase I clinical trial of MultiStem in ischemic stroke

Dec. 18, 2008

Recent patents describe novel agents for neuropsychiatric disorders

Dec. 17, 2008

LCT reports results from preclinical rat studies of NeurotrophinCell in PD

Dec. 17, 2008

Synosia initiates proof-of-concept trial of nitisinone in RLS

Dec. 17, 2008

Impax discusses phase III IPX-056 trial results with FDA

Dec. 17, 2008

First phase III results released for FTY-720, a novel oral therapy for MS

Dec. 17, 2008

Santhera completes recruitment into phase III MICONOS trial of SNT-MC17

Dec. 16, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...